Cancer-associated fibroblasts in ovarian cancer: research progress

Ovarian cancer, known for its high invasiveness and therapeutic resistance, is one of the leading causes of death from gynecological tumors. The tumor microenvironment (TME) plays a crucial role in the development of ovarian cancer, with cancer-associated fibroblasts (CAFs) being a key non-tumor cel...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuance Xu, Danting Sun, Junqi He, Qin Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1504762/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850075071535644672
author Yuance Xu
Danting Sun
Junqi He
Qin Yao
author_facet Yuance Xu
Danting Sun
Junqi He
Qin Yao
author_sort Yuance Xu
collection DOAJ
description Ovarian cancer, known for its high invasiveness and therapeutic resistance, is one of the leading causes of death from gynecological tumors. The tumor microenvironment (TME) plays a crucial role in the development of ovarian cancer, with cancer-associated fibroblasts (CAFs) being a key non-tumor cell component. They significantly affect the prognosis of ovarian cancer by promoting tumor cell proliferation, invasion, metastasis, immune evasion, and drug resistance. The heterogeneity of CAFs provides a new perspective for targeted therapy in ovarian cancer. This review comprehensively analyzes the mechanisms of action, heterogeneity characteristics, and role in the immune microenvironment of CAFs in ovarian cancer, and discusses targeted therapy strategies for CAFs, aiming to provide new theoretical basis and treatment directions for the treatment of ovarian cancer.
format Article
id doaj-art-2d4dbd41b3d94f288919106b8956502d
institution DOAJ
issn 2234-943X
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-2d4dbd41b3d94f288919106b8956502d2025-08-20T02:46:25ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-03-011510.3389/fonc.2025.15047621504762Cancer-associated fibroblasts in ovarian cancer: research progressYuance XuDanting SunJunqi HeQin YaoOvarian cancer, known for its high invasiveness and therapeutic resistance, is one of the leading causes of death from gynecological tumors. The tumor microenvironment (TME) plays a crucial role in the development of ovarian cancer, with cancer-associated fibroblasts (CAFs) being a key non-tumor cell component. They significantly affect the prognosis of ovarian cancer by promoting tumor cell proliferation, invasion, metastasis, immune evasion, and drug resistance. The heterogeneity of CAFs provides a new perspective for targeted therapy in ovarian cancer. This review comprehensively analyzes the mechanisms of action, heterogeneity characteristics, and role in the immune microenvironment of CAFs in ovarian cancer, and discusses targeted therapy strategies for CAFs, aiming to provide new theoretical basis and treatment directions for the treatment of ovarian cancer.https://www.frontiersin.org/articles/10.3389/fonc.2025.1504762/fullovarian cancercancer-associated fibroblasts (CAFs)tumor microenvironmenttargeted therapyimmune microenvironment
spellingShingle Yuance Xu
Danting Sun
Junqi He
Qin Yao
Cancer-associated fibroblasts in ovarian cancer: research progress
Frontiers in Oncology
ovarian cancer
cancer-associated fibroblasts (CAFs)
tumor microenvironment
targeted therapy
immune microenvironment
title Cancer-associated fibroblasts in ovarian cancer: research progress
title_full Cancer-associated fibroblasts in ovarian cancer: research progress
title_fullStr Cancer-associated fibroblasts in ovarian cancer: research progress
title_full_unstemmed Cancer-associated fibroblasts in ovarian cancer: research progress
title_short Cancer-associated fibroblasts in ovarian cancer: research progress
title_sort cancer associated fibroblasts in ovarian cancer research progress
topic ovarian cancer
cancer-associated fibroblasts (CAFs)
tumor microenvironment
targeted therapy
immune microenvironment
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1504762/full
work_keys_str_mv AT yuancexu cancerassociatedfibroblastsinovariancancerresearchprogress
AT dantingsun cancerassociatedfibroblastsinovariancancerresearchprogress
AT junqihe cancerassociatedfibroblastsinovariancancerresearchprogress
AT qinyao cancerassociatedfibroblastsinovariancancerresearchprogress